WHO ARE WE?

The name Exeltis is the indication that we are always in search of perfection and of our existing passion and dedication so as to carry out this perfection.

Why and How?

Company Profile

A step forward in improving health

Exeltis is the result of the natural evolution and sustained growth of the CHEMO pharmaceutical business, an integrated health sciences group. It combines the Group’s know-how and experience with the innovative spirit of Exeltis, becoming a global organization with the capacity to discover, develop, produce and market medicinal products and medical devices that can help to improve the quality of life of millions of people worldwide.

Human wellbeing and health: our driving force

People are our core concern and guiding force. In order to provide better therapeutic solutions and reach more people worldwide, Exeltis has taken its operations to every continent, giving even more patients rapid and effective access to our wide range of products.

Entrepreneurial organization in constant evolution

With our innovative spirit, we use all our know-how, resources and human capital to develop solutions that meet patients’ unsatisfied needs. Our endeavour to find new therapeutic alternatives had led us to join forces with other leading pharmaceutical companies that share our enthusiasm and to establish alliances in order to progress together in healthcare.

Human Welfare and Health:
Our Driving Force

People are our main concern and our guiding force. In order to provide better curative solutions and reach more people around the world, Exeltis has taken its work to every continent, giving more patients quick and effective access to our wide range of products.

Entrepreneurial Organization in Constant Change

With our innovative spirit, we use all our knowledge, resources and human capital to develop solutions that meet the unfulfilled needs of patients. Our initiative to find new therapeutic alternatives has led us to collaborate with other leading pharmaceutical companies who share our excitement and form partnerships to move forward in healthcare together.

Configured regionally around the world;

Exeltis

  • more than 30 affiliates,
  • Balanced portfolio of more than 300 prescription drugs supplied under Leon Farma, Liconsa, Çerkezköy and third party licenses,
  • A strong market in women's health,
  • Sales force with 4000 expert sales representatives.

In the pharmaceutical market; It is a multinational company with its success and experience in more than 40 countries.

What makes us...

Our Values, Vision and Mission

Our Values

  • 30+ affiliates,
  • A balanced portfolio of more than 300 prescription drugs supplied under Leon Farma, Liconsa, Çerkezköy and third party licenses,
  • A strong market in women's health,
  • Sales force with 4000 specialist sales representatives.

Our Vision

The values ​​of continuous improvement, excellence and innovation form the basis of our vision. Our goal is; responding to the unmet medical needs of society.

Our Mission

Millions of people, families and health professionals in their daily lives; provide access to world-class effective treatment solutions; By making a difference to improve future healthcare:

  • Developing innovative treatments.
  • Disseminating our commercial activity around the world.

In the Advancement of Health Innovative Steps...

Review Our Corporate Brochure

40

in over

4000

The team of professionals

300

more than medicine

2000

With more than medical sales representatives

The world is developing rapidly and we are a company that carries out projects on a global scale. within the healthcare organization in order to work more effectively around the world. Going to the division of labor is a perfectly natural process. The birth of strong companies today known as CHEMO, MABXIENCE and EXELTIS is also the experience in INSUDPHARMA. occurred as a result of division of labor.

CHEMO is known as the industrial engine of the group; service to many treatment areas R&D of pharmacological substances that contain chemicals is carried out under the responsibility of CHEMO.

The R&D of biosimilar monoclonal antibodies is an international biotechnology company. It forms the workspace of MABXIENCE.

Finally, the innovative combination of years of knowledge and experience resulting from the continuous growth of INSUDPHARMA EXELTIS, representing the meeting with spirit takes the leading role.

img
in Turkey

Our Production Facilities

Exeltis provides added value to our country's economy with its world-class production facility established on an area of 36.000 m² in the Çerkezköy Organized Industrial Zone.



More Information

<